BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 35116582)

  • 1. Bioinformatic analysis of PLOD family member expression and prognostic value in non-small cell lung cancer.
    Qi Q; Huang W; Zhang H; Zhang B; Sun X; Ma J; Zhu C; Wang C
    Transl Cancer Res; 2021 Jun; 10(6):2707-2724. PubMed ID: 35116582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive Analysis of the Expression, Prognosis, and Biological Significance of PLOD Family in Bladder Cancer.
    Chen R; Jiang M; Hu B; Fu B; Sun T
    Int J Gen Med; 2023; 16():707-722. PubMed ID: 36872941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Prognostic Value of the
    Meng Y; Sun J; Zhang G; Yu T; Piao H
    Front Mol Biosci; 2021; 8():770729. PubMed ID: 35265665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpressing PLOD Family Genes Predict Poor Prognosis in Pancreatic Cancer.
    Zhang J; Tian Y; Mo S; Fu X
    Int J Gen Med; 2022; 15():3077-3096. PubMed ID: 35330878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpressing PLOD family genes predict poor prognosis in gastric cancer.
    Li SS; Lian YF; Huang YL; Huang YH; Xiao J
    J Cancer; 2020; 11(1):121-131. PubMed ID: 31892979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of PLOD Family Genes as Novel Prognostic Biomarkers for Hepatocellular Carcinoma.
    Yang B; Zhao Y; Wang L; Zhao Y; Wei L; Chen D; Chen Z
    Front Oncol; 2020; 10():1695. PubMed ID: 33014843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PLODs are overexpressed in ovarian cancer and are associated with gap junctions via connexin 43.
    Guo T; Gu C; Li B; Xu C
    Lab Invest; 2021 May; 101(5):564-569. PubMed ID: 33483598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of PLODs in Collagen Synthesis and Cancer Progression.
    Qi Y; Xu R
    Front Cell Dev Biol; 2018; 6():66. PubMed ID: 30003082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PLOD1 Is a Prognostic Biomarker and Mediator of Proliferation and Invasion in Osteosarcoma.
    Jiang H; Guo W; Yuan S; Song L
    Biomed Res Int; 2020; 2020():3418398. PubMed ID: 33134376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive analysis of PLOD family members in low-grade gliomas using bioinformatics methods.
    Zhao Y; Zhang X; Yao J
    PLoS One; 2021; 16(1):e0246097. PubMed ID: 33503035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression, Prognosis and Gene Regulation Network of NFAT Transcription Factors in Non-Small Cell Lung Cancer.
    Ma J; Du R; Huang Y; Zhong W; Gui H; Mao C; Song X; Lu J
    Pathol Oncol Res; 2021; 27():529240. PubMed ID: 34257525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation and analysis of expression, prognosis and immune infiltration of WNT gene family in non-small cell lung cancer.
    Wang J; Yang Q; Tang M; Liu W
    Front Oncol; 2022; 12():911316. PubMed ID: 35957916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High ECT2 expression is an independent prognostic factor for poor overall survival and recurrence-free survival in non-small cell lung adenocarcinoma.
    Zhou S; Wang P; Su X; Chen J; Chen H; Yang H; Fang A; Xie L; Yao Y; Yang J
    PLoS One; 2017; 12(10):e0187356. PubMed ID: 29088286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the prognostic and diagnostic values of ALKBH family members in non-small cell lung cancer.
    Wang L; Feng X; Jiao Z; Gan J; Meng Q
    Pathol Res Pract; 2022 Mar; 231():153809. PubMed ID: 35180653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive bioinformatics analysis on exportins in lung adenocarcinoma and lung squamous cell carcinoma.
    Pan M; Huang P; Li L; Lei P; Fang L; Zhao L; Li Y; Huang S; Luo W
    J Thorac Dis; 2023 Apr; 15(4):1872-1891. PubMed ID: 37197486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1 increases cellular proliferation and colony formation capacity in lung cancer via activation of E2F transcription factor 1.
    Li B; Yang H; Shen B; Huang J; Qin Z
    Oncol Lett; 2021 Dec; 22(6):851. PubMed ID: 34733369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression and prognosis of x-ray repair cross-complementing family members in non-small cell lung cancer.
    Fan Y; Gao Z; Li X; Wei S; Yuan K
    Bioengineered; 2021 Dec; 12(1):6210-6228. PubMed ID: 34486486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LINC00628 is differentially expressed between lung adenocarcinoma and squamous cell carcinoma and is associated with the prognosis of NSCLC.
    Liu T; Xu S; Liu X
    Oncol Lett; 2022 Feb; 23(2):55. PubMed ID: 34992687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Combined Detection of Immune Genes for Predicting the Prognosis of Patients With Non-Small Cell Lung Cancer.
    Tian WJ; Liu SS; Li BR
    Technol Cancer Res Treat; 2020; 19():1533033820977504. PubMed ID: 33256552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skp2 expression has different clinicopathological and prognostic implications in lung adenocarcinoma and squamous cell carcinoma.
    Zhong K; Yang F; Han Q; Chen J; Wang J
    Oncol Lett; 2018 Sep; 16(3):2873-2880. PubMed ID: 30127874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.